This review describes the current literature on the interaction between insulin-like growth factors, endocrine hormones, and branched-chain amino acids on muscle physiology in healthy young individuals and during select pathologic conditions. Emphasis is placed on the mechanism by which physical and hormonal signals are transduced at the cellular level to either grow or atrophy skeletal muscle. The key role of the mammalian target of rapamycin and its ability to respond to hypertrophic and atrophic signals informs our understanding how a combination of physical, nutritional, and pharmacologic therapies may be used in tandem to prevent or ameliorate reductions in muscle mass.
|Original language||English (US)|
|Number of pages||26|
|Journal||Endocrinology and Metabolism Clinics of North America|
|State||Published - Jun 2012|
All Science Journal Classification (ASJC) codes
- Endocrinology, Diabetes and Metabolism